Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 16, 1998

View Archived Issues

Schering-Plough and Transgene gene delivery collaboration

Cyclooxygenase type 2, a potential therapeutic target in colon carcinogenesis

Efficacy of eliprodil and combination therapy in a rat embolic stroke model

Company Profile: Anergen

Variagenics granted U.S. patent covering Variagenic Targeting

Parkinson's patch yields positive results

SA-4503 may improve spatial learning performance in rats

JB-9315: a new H2 antagonist with both antisecretory and cytoprotective properties

Imiquimod for selftreatment of external anogenital warts

Vical and Centocor sign agreement for "naked" DNA technology

Amphocil marketing agreement signed for Mexico

Targretin demonstrates high preclinical efficacy in breast tumors

M2 ligands reported for the treatment of dementia

FDA approves CellCept for new indication

Hypocholesterolemic agents disclosed by Warner-Lambert

Orally active iron chelators in development at Novartis

Nonpeptide GnRH antagonists disclosed by Merck & Co.

CCKB/gastrin receptor antagonists with anxiolytic activity discovered at Rotta

Egis patents compounds affecting the central and peripheral serotonergic system

Trega and Ono expand R&D collaboration

KR-30450 exerts cardioprotective effects in ischemic rat hearts

New NSAID from Maruho and Toyama (M-5011) compares favorably with known compounds

Glaxo Wellcome to broaden HIV/AIDS drug pipeline

CDC advisory committee recommends rotavirus vaccine for routine use

Attenuation of AMPA receptor-mediated neurotoxicity by YM-90K

Micronized fenofibrate receives FDA approval

Progenitor discovers novel angiogenesis gene

More data on HMR's malononitrilamides presented at scientific congress

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for December 24, 2024.
Enhanced Cognition: Lewy body dementia phase II pumps stock
BioWorld
Investors will get more details during the International Lewy Body Dementia Conference in Amsterdam late next month, but Wall Street is already buzzing about...
Experimental mRNA gene therapy suppresses preeclampsia in mice
BioWorld MedTech
A gene therapy based on an enhanced lipid nanoparticle (LNP) loaded with vascular endothelial growth factor (VEGF) mRNA could be developed for the treatment of...
Drug duo to Repare lack in gyno cancers? Phase I shows promise
BioWorld
Wall Street wasn’t jumping up and down about Repare Therapeutics Inc.’s early data in gynecological cancers, though the findings look positive and the company has...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.